Table 3 Serum FT4 at different times after treatment
n | 4w | 8w | 12w | ||||
|---|---|---|---|---|---|---|---|
FT4 (pmol/L) | Normalization [(n(%)] | FT4 (pmol/L) | Normalization [(n(%)] | FT4 (pmol/L) | Normalization [(n(%)] | ||
Group A (mild group, lower dose) | 78 | 15(12.7–18.7) | 58(74.4%) | 14.5(12.8–17.6) | 61(78.2%) | 15.7(13.5–17.6) | 63(80.8%) |
Group B (moderate group, higher dose) | 37 | 22.3(13.1–34.8) | 16(43.2%) | 15.9(11.1–18.3) | 27(73.0%) | 16.3(14.1–18.0) | 29(78.4%) |
Group C (severe group, higher dose) | 24 | 23.1(17.2–35.8) | 10(41.7%) | 14.9(11.8–18.4) | 17(70.8%) | 16.4(13.4–19.2) | 17(70.8%) |
Group D (severe group, much higher dose) | 22 | 17.2(14.0-31.8) | 12(54.5%) | 15.7(12.3–17.3) | 18(81.8%) | 15.9(12.4–17.8) | 18(81.8%) |
P | <0.01 | <0.01 | 0.99 | 0.76 | 0.59 | 0.75 | |